Endogenous hormones and the risk of hip and vertebral fractures among older women

New England Journal of Medicine

Volumn 339, Issue 11, 1998, Pages 733-738

  Cummings, Steven R ^a,e   Browner, Warren S ^a   Bauer, Douglas ^a   Stone, Katie ^a   Ensrud, Kristine ^b,c   Jamal, Sophie ^a   Ettinger, Bruce ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d DIVISION OF RESEARCH   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; SEX HORMONE; VITAMIN D;

AGED; AGING; ARTICLE; BONE MARROW CELL; ESTRADIOL BLOOD LEVEL; FEMALE; HIP FRACTURE; HORMONE ACTION; HORMONE BINDING; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; VERTEBRA FRACTURE;

AGED; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HIP FRACTURES; HUMANS; PARATHYROID HORMONE; POSTMENOPAUSE; RANDOM ALLOCATION; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; SPINAL FRACTURES; VITAMIN D;

EID: 0032504985     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199809103391104     Document Type: Article

References (39)

1. Albright F. Osteoporosis. Ann Intern Med 1947;27:861-82.
2. Riggs BL, Melton LJ III. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983;75:899-901.
3. Hordon LD, Peacock M. Osteomalacia and osteoporosis in femoral neck fracture. Bone Miner 1990;11:247-59.
4. Lau EMC, Woo J, Swaminathan R, MacDonald D, Donnan SPB. Plasma 25-hydroxyvitamin D concentration in patients with hip fracture in Hong Kong. Gerontology 1989;35:198-204.
5. Cooper C, Mclaren M, Wood PJ, Coulton L, Kanis JA. Indices of calcium metabolism in women with hip fractures. Bone Miner 1989;5:193-200.
6. Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982;54:115-20.
7. Lund B, Sørensen OH, Lund B, Agner E. Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia: influence of age, renal function and oestrogen therapy. Horm Metab Res 1982;14:271-4.
8. Riggs BL, Ryan RJ, Wahner HW, Jiang N-S, Mattox VR. Serum concentrations of estrogen, testosterone, and gonadotropins in osteoporotic and nonosteoporotic postmenopausal women. J Clin Endocrinol Metab 1973;36:1097-9.
9. Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factors for postmenopausal osteoporosis. Am J Med 1985;78:95-100.
10. van Hemert AM, Birkenhâger JC, De Jong FH, Vandenbroucke JP, Valkenburg HA. Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol (Oxf) 1989;31:499-509.
11. Lips P, Netelenbos JC, Jongen MJM, et al. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 1982;4:85-93.
12. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-73.
13. Cummings SR, Block G, McHenry K, Baron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol 1987;126:796-802.
14. Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 1992;7:625-32.
15. Black DM, Palermo L, Nevitt MC, et al. Comparison of methods for denning prevalent vertebral deformities: the Study of Osteoporotic Fractures J Bone Miner Res 1995;10:890-902.
16. Cummings SR, Melton LJ III, Felsenberg D, et al. Assessing vertebral fractures. J Bone Miner Res 1995;10:518-23. [Erratum, J Bone Miner Res 1995;10:1605.]
17. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
18. Furuyama S, Mayes DM, Nugent CA. A radioimmunoassay for plasma testosterone. Steroids 1970;16:415-28.
19. Mayes D, Nugent CA. Determination of plasma testosterone by the use of competitive protein binding. J Clin Endocrinol Metab 1968;28: 1169-76.
20. Browner WS. Estimating the impact of risk factor modification programs. Am J Epidemiol 1986;123:143-53.
21. Ettinger B, Bainton L, Upmalis DH, Citron JT, VanGessel A. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1997;176:112-7.
22. Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): a randomized controlled trial. JAMA 1996;276:1397-403.
23. Ettinger B, Genant HK, Steiger P, Madvig P. Low-dosage micronized 17β-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992;166:479-88.
24. Genant HK, Lucas I, Weiss S, et al. Low-dose esterified estrogen therapy effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Arch Intern Med 1997;157:2609-15.
25. Naessen T, Berglund L, Ulmsten U. Bone loss in elderly women prevented by ultralow doses of parenteral 17beta-estradiol. Am J Obstet Gynecol 1997;177:115-9.
26. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
27. Dorgan JF, Longcope C, Stephenson HE Jr, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:553-9.
28. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996;11:1531-8.
29. Heshmati HM, Khosla S, Robins SP, Geller N, McAlister CA, Riggs BL. Endogenous residual estrogen levels determine bone resorption even in late postmenopausal women. J Bone Miner Res 1997;12:Suppl 1:S121. abstract.
30. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997;82:3128-35.
31. Lanyon LE. Osteocytes, strain detection, bone modeling and remodeling. Calcif Tissue Int 1993;53:Suppl 1:S102-S106.
32. Dunstan CR, Evans RA, Hills E, Wong SYP, Higgs RJED. Bone death in hip fracture in the elderly. Calcif Tissue Int 1990;47:270-5.
33. Vandewalle B, Lefebvre J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 1989;61:239-46.
34. Longcope C, Baker RS, Hui SL, Johnston CC Jr. Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 1984; 6:309-18.
35. Laufer LR, Davidson BJ, Ross RK, Lagasse LD, Siiteri PK, Judd HL. Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer. Am J Obstet Gynecol 1983;145: 585-90.
36. Riggs BL, Khosla S, Melton LJ III. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-73.
37. Kochersberger G. Primary hyperparathyroidism in the elderly. Compr Ther 1988;14:24-9.
38. Rudman D, Rudman IW, Mattson DE, Nagraj HS, Caindec N, Jackson DL. Fractures in the men of a Veterans Administration nursing home: relation to 1,25-dihydroxyvitamin D. J Am Coll Nutr 1989;8:324-34
39. Lamberg-Allardt C, von Knorring J, Slatis P, Holmstrom T. Vitamin D status and concentrations of serum vitamin D metabolites and osteocalcin in elderly patients with femoral neck fracture: a follow-up study. Eur J Clin Nutr 1989;43:355-61.